000 01271 a2200385 4500
005 20250514015054.0
264 0 _c20020213
008 200202s 0 0 eng d
022 _a1262-3636
040 _aNLM
_beng
_cNLM
100 1 _aCharbonnel, B
245 0 0 _aWhich are the insulin treatment regimens used in France? The "Schema survey".
_h[electronic resource]
260 _bDiabetes & metabolism
_cNov 2001
300 _a591-7 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCross-Sectional Studies
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFrance
650 0 4 _aGlycated Hemoglobin
_xanalysis
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aInsulin
_xadministration & dosage
650 0 4 _aMale
700 1 _aBalarac, N
700 1 _aCazeneuve, B
700 1 _aAugendre-Ferrante, B
700 1 _aLe Thaï, F
700 1 _aDrouin, P
773 0 _tDiabetes & metabolism
_gvol. 27
_gno. 5 Pt 1
_gp. 591-7
999 _c11610455
_d11610455